alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1
                                                                   EXHIBIT 10.38

NABI
--------------------------------------------------------------------------------
                                           5800 PARK OF COMMERCE BOULEVARD, N.W.
                                                            BOCA RATON, FL 33487

                        EFFECTIVE AS OF DECEMBER 11, 2000

Mr. Bruce K. Farley
2387 NW 49th Lane
Boca Raton, FL 33431

Dear Bruce:

         Reference is made to the letter agreement between you and the
undersigned pursuant to which you will receive compensation and other benefits
under certain circumstances in the event of a Change of Control as defined in
such agreement (the "Change of Control Severance Agreement").

         This will confirm that in the event you are entitled to receive
compensation and other benefits under the Change of Control Severance Agreement
and are entitled as well to receive severance or other benefits under an
employment contact or other agreement, you shall be paid under whichever
agreement provides the greatest value to you (as conclusively determined by you)
but not under both agreements.

                                 Very truly yours,

                                 NABI

                                 By /s/ THOMAS H. MCLAIN
                                    -----------------------------------
                                      Name:  Thomas H. McLain
                                      Title:  Sr. VP Corporate Services and CFO

Agreed:


/s/ BRUCE K. FARLEY
-------------------------------
Name:  Bruce K. Farley
Title:  Sr. VP Manufacturing Operations
USDA
Authority


                             SUBSCRIPTION AGREEMENT
                          FOR CONVERTIBLE DEBENTURES IN
                            U.S. DATA AUTHORITY, INC.


         The undersigned  agrees to subscribe to a convertible  debenture in the
amount of $200,000 (U.S.).  This debenture will bear interest at the rate of 10%
per annum from the date of issue.  It will be convertible to preferred  stock at
any time at the rate of $0.20 per share.  The preferred  stock shall have voting
rights equal to 10x the common  stock  voting  rights per share for 3 years from
the date of issue.  After three years, the preferred shares shall  automatically
convert to common  shares with the same rights and  privileges  as the  existing
Section 144 stock.

         This offer is subject to the approval of the Board of Directors.

         This  subscription  should be  accompanied  by the payment of funds and
received by the company by 3:00 p.m. on Thursday, February 15, 2001.

         BY  EXECUTING  BELOW,  THE  UNDERSIGNED  REPRESENTS  THAT  HE/SHE IS AN
ACCREDITED  INVESTOR,  AND AGREES TO COMPLETED  ALL NECESSARY  DOCUMENTATION  TO
SUPPORT THIS REPRESENTATION.


Dated:  2-15-01                                 /s/Joseph Shamy
                                                ----------------
                                                Print Name: Joseph Shamy
                                                Address:
                                                        ------------------------
                                                SSN/TIN:
                                                        ------------------------











            3500 NW Boca Raton Boulevard, Building 811 * Boca Raton,
                 Florida 33431 * Tel (561) 368-0032 * Fax (561)
                             395-5425 * www.usda.net
EXHIBIT 31.2



CERTIFICATION



I, Jasmine Gregory, certify that:



(1) I have reviewed this annual report on Form 10-K of Premier Holding Corp;



(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;



(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;



(4) The Registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:



(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;



(c) Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and



(d) Disclosed in this report any change in the Registrants internal control over financial reporting that occurred during the Registrants most recent fiscal quarter (the Registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrants internal control over financial reporting; and



(5) The Registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrants auditors and the audit committee of the Registrants board of directors (or persons performing the equivalent functions):



(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; and



(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting.



Date:  March 25, 2010



/s/   Jasmine Gregory

Jasmine Gregory

Chief Financial Officer, and Director
[Federal Register Volume 75, Number 93 (Friday, May 14, 2010)]
[Notices]
[Page 27353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-11188]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT

[Docket No. FR-5375-N-18]


Federal Property Suitable as Facilities to Assist the Homeless

AGENCY: Office of the Assistant Secretary for Community Planning and 
Development, HUD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This Notice identifies unutilized, underutilized, excess, and 
surplus Federal property reviewed by HUD for suitability for possible 
use to assist the homeless.

DATES: Effective Date: May 14, 2010.

FOR FURTHER INFORMATION CONTACT: Kathy Ezzell, Department of Housing 
and Urban Development, 451 Seventh Street, SW., Room 7262, Washington, 
DC 20410; telephone (202) 708-1234; TTY number for the hearing- and 
speech-impaired (202) 708-2565, (these telephone numbers are not toll-
free), or call the toll-free Title V information line at 800-927-7588.

SUPPLEMENTARY INFORMATION: In accordance with the December 12, 1988 
court order in National Coalition for the Homeless v. Veterans 
Administration, No. 88-2503-OG (D.D.C.), HUD publishes a Notice, on a 
weekly basis, identifying unutilized, underutilized, excess and surplus 
Federal buildings and real property that HUD has reviewed for 
suitability for use to assist the homeless. Today's Notice is for the 
purpose of announcing that no additional properties have been 
determined suitable or unsuitable this week.

    Dated: May 6, 2010.
Mark R. Johnston,
Deputy Assistant Secretary for Special Needs.
[FR Doc. 2010-11188 Filed 5-13-10; 8:45 am]
BILLING CODE 4210-67-P
No. 1,608.

#### In re KELLY’S ESTATE.

*Appeal from District*Court, *Silver Bow Countyj John Lind*say, *Judge.*

Decided June 18, 1903.

*Mr. L. P.*Forrestell, for Appellant.

Pee Curiam.

This cause having been set for hearing this day, and no briefs having been filed, it- is ordered that the appeal herein be and the same is hereby dismissed.
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

No. 15-969V

Filed: December 3, 2015

Unpublished

* * * * * * * * * * * * * * * * * * * * * * * * * * * *

FRANK STENDAL, *

*

Petitioner, * Ruling on Entitlement; Concession;

* Tetanus-diphtheria-acellular pertussis

* (“Tdap”); Shoulder Injury (“SIRVA”);

SECRETARY OF HEALTH * Special Processing Unit (“SPU”)

AND HUMAN SERVICES, *

*

Respondent. *

*

* * * * * * * * * * * * * * * * * * * * * * * * * * * *

Paul Brazil, Muller Brazil, LLP, Dresher, PA, for petitioner.

Traci Patton, U.S. Department of Justice, Washington, DC, for respondent.

RULING ON ENTITLEMENT1

Dorsey, Chief Special Master:

On September 3, 2015, Petitioner filed a petition for compensation under the 

National Vaccine Injury Compensation Program, 42 U.S.C. §300aa-10, et seq.,

2 [the 

“Vaccine Act” or “Program”]. Petitioner alleges that he suffered a shoulder injury 

following receipt of his September 2, 2014 Tetanus-diphtheria and acellular pertussis 

(“Tdap”) vaccination. Petition at 2. The case was assigned to the Special Processing 

Unit of the Office of Special Masters.

On December 3, 2015, respondent filed her Rule 4(c) report in which she 

concedes that petitioner is entitled to compensation in this case. Respondent’s Rule 

4(c) Report at 1. Specifically, respondent “has concluded that petitioner’s injury is 

consistent with shoulder injury related to vaccine administration (“SIRVA”), and that it 

was caused in fact by the Tdap vaccine he received on or about September 2, 2014.” 

Id. at 4. Respondent further agrees that no other cause of petitioner’s injury has been 

 1 Because this unpublished ruling contains a reasoned explanation for the action in this case, the 

undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with 

the E-Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended 

at 44 U.S.C. § 3501 note (2006)). In accordance with Vaccine Rule 18(b), petitioner has 14 days to 

identify and move to redact medical or other information, the disclosure of which would constitute an 

unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits 

within this definition, the undersigned will redact such material from public access.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for 

ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 

300aa (2012).
identified, that the sequela of petitioner’s injury persisted for more than six months, and 

that petitioner has met the statutory requirements for entitlement to compensation. Id.

In view of respondent’s concession and the evidence before me, the 

undersigned finds that petitioner is entitled to compensation.

IT IS SO ORDERED.

s/Nora Beth Dorsey

Nora Beth Dorsey

Chief Special Master
<PAGE>


EXHIBIT 10.6

                            RELEASE OF STOCK OPTIONS


         This Release of Stock Options is executed this the 5th day of June,
2000 by C. Roger Jones ("Jones") for the benefit of and in favor of ADVA
International, Inc., formerly known as Advanced Medical Products, Inc., a
Delaware corporation (the "Corporation").

         WHEREAS, Jones is the grantee of certain options (the "Options") to
purchase common stock of the Corporation pursuant to the Amended and Restated
Stock Option Plan of the Corporation; and

         WHEREAS, the Options presently have no value to Jones, as the exercise
price substantially exceeds the market price of the underlying common stock; and

         WHEREAS, Jones has agreed to release the Options in furtherance of a
transaction pursuant to which the Corporation will engage in a share exchange
with the shareholders of Global Information Group USA Inc., a Delaware
corporation, from which transaction Jones expects to benefit as a shareholders
of the Corporation.

         NOW, THEREFORE, in consideration of the foregoing premises and other
valuable consideration as set forth herein, Jones does hereby release and
quit-claim in favor of the Corporation any interest Jones may have in the
Options. Jones acknowledges that, effective upon the execution of this Release,
he has no further option or right to acquire any class of the capital stock of
the Corporation.

         IN WITNESS WHEREOF, Jones has executed this Release under seal
effective as of the date first set forth above.


         /s/ C. Roger Jones
         -------------------
         C. Roger Jones
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Federal Reserve System

The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).

The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than May 28, 2010.

**A. Federal Reserve Bank of San Francisco**                     (Kenneth Binning, Vice President, Applications and Enforcement) 101 Market Street, San Francisco, California 94105-1579:                

*1. Hilario John Arguinchona and Karen Arguinchona*, Boise, Idaho; to retain voting shares of Syringa Bancorp, and thereby indirectly retain voting shares Syringa Bank, both of Boise, Idaho.                

Board of Governors of the Federal Reserve System, May 10, 2010.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. 2010-11439 Filed 5-12-10; 8:45 am]

BILLING CODE 6210-01-S
<PAGE>   1

                                                                    EXHIBIT 23

                        CONSENT OF INDEPENDENT AUDITORS

     We consent to the incorporation by reference in this Annual Report (Form
10-K) of Cerulean Companies, Inc. of our report dated February 6, 1997, included
in the 1996 Annual Report to Shareholders of Cerulean Companies, Inc.

     Our audits also included the financial statement schedules of Cerulean
Companies, Inc. listed in Item 14(a). These schedules are the responsibility of
the Company's management. Our responsibility is to express an opinion based on
our audits. In our opinion, the financial statement schedules referred to above,
when considered in relation to the basic financial statements taken as a whole,
present fairly in all material respects the information set forth therein.


                                                 /s/ Ernst & Young LLP


February 6, 1997
Atlanta, Georgia

                                   Page 50
No. 1,681.

#### MURRAY, Appellant, *v.*LIVINGSTON, Respondent.

*Appeal from District*Court, *Parle County; Frank*Henry, *Judge.*

On motion to dismiss appeal.

Decided October 15, 1903.

*Mr. A. P.*Stark, for Appellant.

*Mr. James*Donovan, for Respondent.

Per Curiam.

Upon motion to dismiss the appeal, it is ordered by the court that the appeal herein be and the same is hereby dismissed.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, May 19, 2010, 12 p.m. to May 19, 2010, 5 p.m., Tata Communications, 2355 Dulles Corner Boulevard, 7th Floor, Herndon, VA 20171 which was published in the                     **Federal Register**                     on April 26, 2010, 75 FR 21641.                

The meeting has been changed to a Hybrid meeting. The meeting date, time and location remain the same. The meeting is closed to the public.

Dated: April 29, 2010.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010–10871 Filed 5–6–10; 8:45 am]

BILLING CODE 4140–01–P
| (1)   | The      Report fully complies with the requirements of section 13(a) or 15(d) of      the Securities Exchange Act of 1934;and |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------|

| (2)   | The      information contained in the Report fairly presents, in all material      respects, the financial condition and results of operations of the Company      as of the dates and for the periods expressed in the    Report. |
|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:  October      31, 2008 | /s/      Stephen A. Romano                         |
|----------------------------------------|----------------------------------------------------|
|                                   | Stephen      A. RomanoChief      Executive Officer |
|                                   |                                               |
|                                   | /s/      Jeffrey R. Feeler                         |
|                                   | Jeffrey      R. FeelerChief      Financial Officer |

----
EXHIBIT
23

INDEPENDENT
AUDITORS CONSENT

Board
of Directors
Global Med Technologies, Inc. and Subsidiary:

We consent to
the incorporation  by reference in  Registration  Statements (No.  333-28155, No.
333-39193, No. 333-45031, No. 333-69851, No. 333-60672, and No. 333-60674) on Form S-8 of
Global Med Technologies,  Inc. and subsidiary,  of our report  dated February 6, 2004,
except for Notes 2 and 11, as to which are dated April 14, 2004,
appearing in the Annual Report on Form 10-K of Global Med  Technologies,  Inc. and
subsidiary for the years ended December 31, 2003, 2002 and 2001.

/s/
Ehrhardt Keefe Steiner & Hottman PCEhrhardt Keefe Steiner & Hottman
PC

Denver,
ColoradoApril 14, 2004
No. 3,127.

#### ELLEN MACKEL, Respondent, *v.*ALEXANDER MACKEL, Appellant.

*Appeal from District Court, Silver Bow County; W. B. C. Stewart, Judge of the Ninth Judicial District, presiding.*

Decided December 16, 1914.

*Mr. J. E. Eealy*and *Mr. Wm. Meyer,*for Appellant.

PER CURIAM.

It is ordered that the appeal in the above-entitled cause be, and the same is hereby, dismissed in accordance with *praecipe*of appellant.
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, Yaron Arbell, Chief Executive Officer of B&D Food Corp., hereby
certifies,  pursuant to 18 U.S.C.  Section 1350, as adopted  pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:

(1)   the  quarterly  report on Form  10-QSB/A  of B&D Food Corp.  for the three
      months  ended  March  31,  2006 (the  "Report")  fully  complies  with the
      requirements  of Section 13(a) or 15(d) of the Securities  Exchange Act of
      1934; and

(2)   the information  contained in the Report fairly presents,  in all material
      respects,  the  financial  condition and results of operations of B&D Food
      Corp.

Dated: May 15, 2006

                                          /s/ YARON ARBELL
                                          -------------------------------------
                                          Yaron Arbell
                                          Chief Executive Officer
                                          (Principal Executive Officer)

A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
required  by  Section  906,  has been  provided  to B&D Food  Corp.  and will be
retained  by B&D  Food  Corp.  and  furnished  to the  Securities  and  Exchange
Commission or its staff upon request.
<PAGE>

                                  EXHIBIT 21.1

                       LIST OF SUBSIDIARIES OF THE COMPANY

                      THE MAJOR AUTOMOTIVE COMPANIES, INC.

                             MAJOR ACQUISITION CORP.
                          Major Automotive Group, Inc.
                              Major Chevrolet, Inc.
                    Major Chrysler Plymouth Jeep Eagle, Inc.
                                Major Dodge, Inc.
                                 Major Kia, Inc.

                      MAJOR AUTOMOTIVE OF NEW JERSEY, INC.
                          Compass Lincoln-Mercury, Inc.
                               Compass Dodge, Inc.

                          MAJOR ORANGE PROPERTIES, LLC

                          MAJOR AUTOMOTIVE REALTY CORP.

                              HEMPSTEAD MAZDA, INC.

                               MAJOR NISSAN, INC.

                      MID-ATLANTIC TELECOMMUNICATIONS, INC.

                           MAJOR FLEET & LEASING CORP.

                                       1